Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Knight Therapeutics Inc KHTRF

Primary Symbol: T.GUD

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Add To Watchlist

Recent & Breaking News (TSX:GUD)

Knight Announces Filing of New Drug Submission for Ibsrela(TM) in Canada

GlobeNewswire June 26, 2019

Medison Establishes Canada's Only Innovative Pharma Commercial Company

Business Wire June 25, 2019

Medison Issues Open Letter to Knight Therapeutics Shareholders Urging Jonathan Goodman to Build Real Business during the Grace Period Knight Received

Business Wire June 19, 2019

Knight has less skin in Medimetriks through full loan repayment

GlobeNewswire June 18, 2019

Medimetriks Pharmaceuticals Focuses on Advancing MM36 (difamilast) Through Phase 3 Trials; Extinguishes Debt Owed to Knight Therapeutics

PR Newswire June 18, 2019

Knight to Present at the Raymond James Life Sciences and MedTech Conference in New York City

GlobeNewswire June 11, 2019

Knight to Present at the Jefferies 2019 Global Healthcare Conference in New York City

GlobeNewswire May 28, 2019

Knight to Present at the National Bank Financial Markets 9th Annual Quebec Conference in Toronto

GlobeNewswire May 23, 2019

Knight to Present at the 2019 RBC Capital Markets Global Healthcare Conference in New York City

GlobeNewswire May 15, 2019

Knight Reports First Quarter 2019 Results

GlobeNewswire May 9, 2019

GUD Day for Knight: Shareholders Vote Overwhelmingly in Favour of Management

GlobeNewswire May 7, 2019

Medison Creates Significant Change at Knight Therapeutics

Business Wire May 7, 2019

Medison Campaign Successfully Creates Unanimous Consent for Change at Knight Therapeutics

Business Wire May 3, 2019

Notice of Knight Therapeutics' First Quarter 2019 Results Conference Call

GlobeNewswire May 2, 2019

As Deadline Approaches, Knight Therapeutics Reminds Shareholders to Vote the BLUE Proxy for Nominees Who Support Jonathan Goodman's Vision

GlobeNewswire May 1, 2019

Medison Urges Knight Shareholders to Demand Answers to Critical Questions from Jonathan Goodman at the Bloom Burton & Co. Healthcare Investor Conference

Press Releases April 30, 2019

Medison Urges Knight Shareholders to Demand Answers to Critical Questions from Jonathan Goodman at the Bloom Burton & Co. Healthcare Investor Conference

Business Wire April 30, 2019

Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison's Highly Qualified Nominees at Upcoming Annual Meeting

Canada NewsWire April 29, 2019

Second Leading Independent Proxy Advisory Firm Supports Medison and Recommends Change and a New Strategy at Knight Therapeutics

Business Wire April 26, 2019

Second Leading Independent Proxy Advisory Firm Supports Medison and Recommends Change and a New Strategy at Knight Therapeutics

Press Releases April 26, 2019